MRNA expression of adipocytokines and glucocorticoid-related genes are associated with downregulation of E-cadherin mRNA in colorectal adenocarcinomas

International Journal of Colorectal Disease

Volumn 27, Issue 8, 2012, Pages 1021-1027

  Størkson, Ragnhild H ^a   Aamodt, Rolf ^b   Vetvik, Katja Kannisto ^b   Pietilainen, Kirsi ^e   Bukholm, Geir ^b   Jonsdottir, Kristin ^c   Vollan, Hilde S ^b,c   Sonerud, Tonje ^c   Lüders, Torben ^c   Jacobsen, Morten B ^c,d   Bukholm, Ida R K ^b  

^a Ostfold Hospital Trust   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Colorectal adenocarcinoma; EMT; Microarray; QRT PCR

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

11BETA HYDROXYSTEROID DEHYDROGENASE 1 GENE; ADIPOCYTOKINE GENE; ADULT; AGED; ARTICLE; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; E CADHERIN GENE; GENE; GENE CONTROL; GENE OVEREXPRESSION; GLUCOCORTICOID RECEPTOR ALPHA GENE; GLUCOCORTICOID RELATED GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERLEUKIN 10 GENE; INTERLEUKIN 1RN GENE; INTERLEUKIN 6 GENE; INTERLEUKIN 8 GENE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1 GENE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLUG GENE; SNAIL GENE; SURGICAL PATIENT; TISSUE MICROARRAY; TISSUE SECTION; TUMOR NECROSIS FACTOR ALPHA GENE; VIMENTIN GENE;

ADENOCARCINOMA; ADIPOKINES; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; COLORECTAL NEOPLASMS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GLUCOCORTICOIDS; HUMANS; INTESTINAL MUCOSA; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84864459256     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1442-6     Document Type: Article

References (29)

1. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-Analysis of prospective observational studies. Lancet 371:569-578
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638
3. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579-591
4. Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738
5. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K (2002) Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 11:385-391
6. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F (2001) Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 10:937-941
7. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A, Savage PJ (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91:1147-1154
8. Fasshauer M, Paschke R (2003) Regulation of adipocytokines and insulin resistance. Diabetologia 46:1594-1603
9. Rajala MW, Scherer PE (2003) Minireview: The adipocyte-At the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765-3773
10. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE (2003) Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-Apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22:6408-6423
11. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454
12. Loskutoff DJ, Quigley JP (2000) PAI-1, fibrosis, and the elusive provisional fibrin matrix. J Clin Invest 106:1441-1443
13. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Hofler H, Janicke F, Graeff H (1997) Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 78:285-296
14. Zhao H, Langerod A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Karesen R, Botstein D, Borresen-Dale AL, Jeffrey SS (2004) Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 15:2523-2536
15. Andrews RC, Walker BR (1999) Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci (Lond) 96:513-523
16. Qi D, Rodrigues B (2007) Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab 292:E654-E667
17. Bujalska IJ, Draper N, Michailidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA, Stewart PM (2005) Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 betahydroxysteroid dehydrogenase type 1. JMol Endocrinol 34:675-684
18. Draper N,Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I,Malunowicz E,White PC, Hewison M, Mason PJ, Connell JM, Shackleton CH, Stewart PM (2003) Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 34:434-439
19. Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Ferno M, Eppenberger-Castori S, Sweep CG, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Brunner N, Duggan C, Lisboa BW, Bendahl PO, Quillien V, Daver A, Ricolleau G, Meijer-Van Gelder ME, Manders P, Fiets WE, Blankenstein MA, Broet P, Romain S, Daxenbichler G,Windbichler G, Cufer T, Borstnar S, Kueng W, Beex LV, Klijn JG, O'Higgins N, Eppenberger U, Janicke F, Schmitt M, Foekens JA (2002) Pooled analysis of prognostic impact of urokinase-Type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 94:116-128
20. Praus M,Wauterickx K, Collen D, Gerard RD (1999) Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors. Gene Ther 6:227-236
21. Wibe A, Eriksen MT, Syse A, Tretli S, Myrvold HE, Soreide O (2005) Effect of hospital caseload on long-Term outcome after standardization of rectal cancer surgery at a national level. Br J Surg 92:217-224
22. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121
23. Hashimoto K, Goto S, Kawano S, Aoki-Kinoshita KF, Ueda N, Hamajima M, Kawasaki T, Kanehisa M (2006) KEGG as a glycome informatics resource. Glycobiology 16:63R-70R
24. Wakefield LM, Roberts AB (2002) TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12:22-29
25. Atreya R, Neurath MF (2005) Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol 28:187-196
26. Lahm H, Petral-Malec D, Yilmaz-Ceyhan A, Fischer JR, Lorenzoni M, Givel JC, Odartchenko N (1992) Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1. Eur J Cancer 28A:1894-1899
27. Isomoto H, Mott JL, Kobayashi S, Werneburg NW, Bronk SF, Haan S, Gores GJ (2007) Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing. Gastroenterology 132:384-396
28. Schneider MR, Hoeflich A, Fischer JR, Wolf E, Sordat B, Lahm H (2000) Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett 151:31-38
29. Herszenyi L, Plebani M, Carraro P, De PM, Roveroni G, Cardin R, Tulassay Z, Naccarato R, Farinati F (1999) The role of cysteine and serine proteases in colorectal carcinoma. Cancer 86:1135-1142